A. DiFrancesco

675 citations
12 papers · 522 indexed · h-index 8
Topics
Osteoarthritis Treatment and Mechanisms (7 papers)Knee injuries and reconstruction techniques (3 papers)Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers)

In The Last Decade

A. DiFrancesco

11 papers receiving 510 citations

Peers

A. DiFrancesco
Comparison fields: 5 of 59
  • Rheumatology 259
  • Immunology 139
  • Pharmacology 137
  • Molecular Biology 126
  • Oncology 111
Replace Toshiyuki Ikeda with:
Toshiyuki Ikeda Japan
Elizabeth Hutto United States
T Leizer Australia
Claire Deligne France
Daichi Hoshina Japan
Gregory Kumkumian United States
M.B. Bennink Netherlands
E.U. Sumer Denmark
Hye-Joa Oh South Korea
Susan C. Ridge United States
A. DiFrancesco relative to Toshiyuki Ikeda Japan Toshiyuki Ikeda's profile →
Citations per field
00.5×6.2×
Toshiyuki Ikeda · 1×
Citations per year

Countries citing papers authored by A. DiFrancesco

Since Specialization
Citations

This map shows the geographic impact of A. DiFrancesco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. DiFrancesco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. DiFrancesco more than expected).

Fields of papers citing papers by A. DiFrancesco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. DiFrancesco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. DiFrancesco. The network helps show where A. DiFrancesco may publish in the future.

Co-authorship network of co-authors of A. DiFrancesco

This figure shows the co-authorship network connecting the top 25 collaborators of A. DiFrancesco. A scholar is included among the top collaborators of A. DiFrancesco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. DiFrancesco. A. DiFrancesco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 0
2 1
3 73
4 108
5 9
6 9
7 17
8 3
9 108
10 1
11 127
12 66

About A. DiFrancesco

A. DiFrancesco is a scholar working on Rheumatology, Pharmacy and Psychiatry and Mental health, having authored 12 papers that have together received 522 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (7 papers), Knee injuries and reconstruction techniques (3 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (2 papers). The work is most often cited by research in Rheumatology (259 citations), Pharmacology (137 citations) and Immunology (139 citations). A. DiFrancesco has collaborated with scholars based in United States, Malaysia and Mexico. Frequent co-authors include Allan Gibofsky, Yusuf Yazıcı, J. Tambiah, Marc C. Hochberg, Christopher J. Swearingen, Timothy E. McAlindon, Nancy E. Lane, Nebojša Skrepnik, İsmail Şimşek and Morgan H. Jones. Their work appears in journals such as Clinical Cancer Research, Annals of the Rheumatic Diseases and Vaccine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026